Arch Biopartners Inc. is seeking candidates for the position of Research and Development Scientist.
Duration: One year with potential for extension pending availability of funding.
Start Date: As soon as possible.
Salary: $75,000 CAD/yr.
Job Description: Arch Biopartners Inc., with laboratories based at the University of Calgary, is accepting applications for a full-time position for a R&D Scientist with specialization in protein biochemistry and molecular biology to support development of the Metablok (LSALT) program. The successful candidate will be working in the laboratory of Dr. Daniel A. Muruve, Chief Scientific Officer and Professor at the University of Calgary. Research activities will be conducted in the development of the LSALT peptide, a novel anti-inflammatory molecule designed to target acute kidney injury and other pro-inflammatory diseases. A variety of molecular, biochemical and cellular approaches are employed using cell culture as well as in vivo mousemodels, HPLC, mass spectrometry and other protein-based techniques.
The responsibilities of this position will include:
Qualifications/Expertise Required: The ideal candidate will be a Ph.D. graduate in cell and molecular biology with expertise in protein/peptide analysis.
In addition, the individual should have:
Application details: Applications should be submitted by e-mail to the following contact, with the subject line “Arch Biopartners: R&D Scientist Position”. Please include a cover letter, your CV and the names and contact information of a least three relevant external references to:
Dr. Arthur Lau
All qualified candidates are encouraged to apply; however, Canadian citizens and permanent residents will be given priority. The application deadline is July 31, 2019.
About Arch Biopartners Inc.
Arch Biopartners Inc. is focused on the development of innovative technologies that have the potential to make a significant medical or commercial impact. Arch has established a diverse portfolio that includes Metablok, a potential treatment for inflammation, sepsis and cancer metastasis; AB569, a potential new treatment for antibiotic resistant bacterial infections in the lung, urinary tract or wounds; and, ‘Borg’ peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.
For more information on Arch Biopartners, its technologies and other public documents Arch has filed on SEDAR, please visit www.archbiopartners.com
About the University of Calgary
The University of Calgary is Canada’s leading next-generation university – a living, growing and youthful institution that embraces change and opportunity with a can-do attitude. Located in the nation’s most enterprising city, the university is making tremendous progress on its Eyes High journey to be recognized as one of Canada’s top five research universities, grounded in innovative learning and teaching and fully integrated with the community it both serves and leads.
For more information, visit ucalgary.ca.
About Calgary, Alberta
Calgary is one of the world's most livable cities for years. Calgary is a city of leaders – in business, community, philanthropy and volunteerism. Calgarians benefit from one of the strongest economies in the nation and enjoy more days of sunshine per year than any other major Canadian city. Calgary is less than an hour’s drive from the Rocky Mountains and boasts the most extensive urban pathway and bikeway network in North America. We strive to recruit individuals who will further enhance our diversity and will support their professional success while they are here. We encourage all qualified applicants to apply, however preference will be given to Canadian citizens and permanent residents of Canada
Job Type: Full-time
Salary: $75,000.00 /year